EA Newsletter

CatalystEA NewsletterDealsTEST
EA NewsletterEA Newsletter
The AI Trade Sitting in the Middle of Every Data Center Deal

The AI Trade Sitting in the Middle of Every Data Center Deal

Wall Street ignored this middleman while chasing chip stocks. That mistake ends today.

EA NewsletterEA Newsletter
The Overlooked 3M Spinoff Just Caught a Fresh Buy Rating

The Overlooked 3M Spinoff Just Caught a Fresh Buy Rating

A major bank just called the bottom days before earnings could confirm it.

EA NewsletterEA Newsletter
When the Founder Keeps Buying His Own Stock Right Before a $1.275B Deal Closes

When the Founder Keeps Buying His Own Stock Right Before a $1.275B Deal Closes

Executives quietly wrote personal checks for shares, so what do they see that we don't?

EA NewsletterEA Newsletter
The Cortisol Play With an FDA Approval and an Oncology Kicker

The Cortisol Play With an FDA Approval and an Oncology Kicker

The under-the-radar biotech just scored a game-changing approval

EA NewsletterEA Newsletter
The Pain-Killer Play Sitting on a Kidney Drug Kicker

The Pain-Killer Play Sitting on a Kidney Drug Kicker

A 20-year silence just broke, and it could rewrite how millions manage pain without opioids

EA NewsletterEA Newsletter
The $39B Power Name Where Options Traders Just Placed a Very Loud Bet

The $39B Power Name Where Options Traders Just Placed a Very Loud Bet

Someone just made a massive bet before the bell and the stock hasn't budged yet.

EA NewsletterEA Newsletter
The AI Power Chip Setup That's Coiled Right Under Resistance

The AI Power Chip Setup That's Coiled Right Under Resistance

The overlooked AI pick hiding inside every data center — before Wall Street catches on.

EA NewsletterEA Newsletter
The Used-Car Retailer Barclays Just Called a Buy While the Stock Surged

The Used-Car Retailer Barclays Just Called a Buy While the Stock Surged

A mid-cap auto retailer just caught a fresh Barclays upgrade the same day the stock posted a solid gain.

EA NewsletterEA Newsletter
The $170B Revenue Machine the Market Is Undervaluing

The $170B Revenue Machine the Market Is Undervaluing

When an insider bets $7.2M of his own money, smart investors pay attention.

EA NewsletterEA Newsletter
The Gene Therapy Name Analysts Keep Racing to Upgrade

The Gene Therapy Name Analysts Keep Racing to Upgrade

Analysts keep bumping their targets on this $10B biotech. And the biggest pipeline catalysts are still ahead.

EA NewsletterEA Newsletter
The AI Infrastructure Story Hiding Behind a $14 Billion Networking Deal

The AI Infrastructure Story Hiding Behind a $14 Billion Networking Deal

Wall Street sees a networking merger. Smart money sees something far bigger brewing.

EA NewsletterEA Newsletter
The Beaten-Down Healthcare Name Setting Up a Breakout

The Beaten-Down Healthcare Name Setting Up a Breakout

The setup nobody's talking about while the crowd chases oil and chips